Literature DB >> 17057048

Effectiveness of half-dose versus full-dose influenza vaccine in health care workers.

Joan S Kramer1, Chris Durham, Todd Schroeder, James C Garrelts.   

Abstract

PURPOSE: A prospective, randomized, double-blind study comparing the effectiveness of half-dose versus full-dose trivalent inactivated influenza vaccine (TIV) in health care workers was conducted.
METHODS: The study was conducted at a 760-bed tertiary care community hospital. Study participants (n = 444) were hospital staff or employees over 18 years of age who were enrolled during a two-week period in October and November 2004. Participants were assigned to either full-dose (n = 222) or half-dose (n = 222) TIV. The participants completed a standardized questionnaire monthly from November 2004 through March 2005. The primary outcome was the incidence of influenza between the two groups; the secondary outcomes were self-reported days of work missed as a result of influenza and the proportion of participants in each group self-reporting signs and symptoms of influenza. Laboratory confirmation of influenza diagnosis was sought in participants reporting a clinical diagnosis by their physicians. Differences in the groups were analyzed with Fisher's exact test, with a < 0.05 considered significant.
RESULTS: There was no difference between the full-dose and half-dose groups in the diagnosis of influenza (4% versus 7%, p = 0.198). Laboratory confirmation of an influenza diagnosis occurred in one participant who received full-dose TIV.
CONCLUSION: Half-dose TIV demonstrated a similar effectiveness to full-dose TIV, measured by the number of diagnoses of influenza and symptom survey of participating health care workers. Administration of half-dose TIV is an acceptable strategy for maximizing the number of vaccinations in health care workers, but additional studies are needed to confirm the comparable immunogenicity and effectiveness between the two doses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17057048     DOI: 10.2146/ajhp050525

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  3 in total

1.  Immunogenicity of a half-dose of adjuvanted 2009 pandemic H1N1 influenza vaccine in adults: a prospective cohort study.

Authors:  B L Coleman; S P Kuster; J Gubbay; D Scheifele; Y Li; D Low; N Crowcroft; T Mazzulli; L Shi; S A Halperin; B Law; A McGeer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-28       Impact factor: 3.267

2.  Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.

Authors:  Robert W Frenck; Robert Belshe; Rebecca C Brady; Patricia L Winokur; James D Campbell; John Treanor; Christine M Hay; Cornelia L Dekker; Emmanuel B Walter; Thomas R Cate; Kathryn M Edwards; Heather Hill; Mark Wolff; Tom Leduc; Nadia Tornieporth
Journal:  Vaccine       Date:  2011-06-23       Impact factor: 3.641

Review 3.  Regulatory mechanisms for absenteeism in the health sector: a systematic review of strategies and their implementation.

Authors:  Angela N Kisakye; Raymond Tweheyo; Freddie Ssengooba; George W Pariyo; Elizeus Rutebemberwa; Suzanne N Kiwanuka
Journal:  J Healthc Leadersh       Date:  2016-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.